Biomerica (BMRA) announced that its Fortel Kidney Disease Test has been approved for sale by the United Arab Emirates Ministry of Health and Prevention. This key regulatory milestone enables Biomerica to offer its test across the UAE, a region facing a high burden of chronic kidney disease.
Claim 70% Off TipRanks This Holiday Season
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on BMRA: